A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple sclerosis: the CLEAR study methods and status update
Kerstin Hellwig(St. Josef-Hospital), Tahani Boumenna(Research & Development Institute), Sandra Vukusic(Université Claude Bernard Lyon 1), Xiaolei Zhou(Guangxi Medicinal Botanical Garden), Alison Tse Kawai(RTI Health Solutions), Maarit K. Leinonen(University of Helsinki), Thomas M. MacDonald(Ninewells Hospital), Rachel Weinrib, Carolyn E. Cesta(Karolinska Institutet), Stig Wergeland(Haukeland University Hospital), Alejandro Arana, Melinda Magyari(University of Copenhagen), Alexandra Lauer(Merck KGaA, Darmstadt (Germany)), Asher Ornoy(Ariel University)
Cited by 1
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Multiple sclerosis
|Nature Reviews Disease Primers|2018|1.4k
Multiple Sclerosis Severity Score
|Neurology|2005|959
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624
Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa
|American Journal of Psychiatry|2017|603